Connect with us

Health

Oral drug for spinal muscular atrophy to be available on NHS in England – The Guardian

About 1,500 patients expected to benefit from risdiplam, which can be taken as syrup at home

Published

on

NHSAbout 1,500 patients expected to benefit from risdiplam, which can be taken as syrup at home
Fri 19 Nov 2021 06.00 GMT
The NHS is to introduce a revolutionary new treatment to tackle the leading genetic cause of death among babies and young children.

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending